It is a healthcare public limited company based in Delhi, Delhi, India, established in 2008.
2008 | Delhi, Delhi, India | ActiveAbbott Pharma Limited, a active public limited company, was established on 24 April 2008 in Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the hospital and medical care sector, it holds CIN: U24232DL2008PLC177143. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Pankaj Kumar Jha (Director), Man Mohan Sharma (Director), Neetika Goel (Director). Past directors included Harish Kumar, Manisha Manocha, Jaswant Singh. Its latest AGM occurred on 11 May 2025, with the balance sheet filed on 31 March 2025. It is based at 303, Plot No. 2, 3Rd Floor, Vardhman Avon Shopping Plaza, Block-C, Saraswati Vihar, Delhi, Delhi, 110034.
U24232DL2008PLC177143
177143
24 April 2008
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Abbott Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Kumar Jha | Director | 08 Jun 2018 | Current |
| Man Mohan Sharma | Director | 08 Apr 2023 | Current |
| Neetika Goel | Director | 08 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Mar 2009 | Past |
| Pramod Abcsdd | Director | 10 Mar 2009 | Past |
| Pramod Abcsdd | Additional Director | 21 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 12 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 03 May 2024 | Past |
| Pramod Abcsdd | Director | 03 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abbott Pharma Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 3.65% decrease. The company also saw a substantial improvement in profitability, with a 20.13% increase in profit. The company's net worth moved up by a moderate rise of 4.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Abbott Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Abbott Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Abbott Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbott Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Abbott Pharma Limited last Annual general meeting of members was held on 11 May 2025 as per latest MCA records. was documented.
Progress on Abbott Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Neetika Goel was appointed as a Director was appointed as a Director on 08 Nov 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on Man Mohan Sharma was appointed as a Director was appointed as a Director on 08 Apr 2023 & has been associated with this company since 2 years 9 months . was documented.
Pankaj Kumar Jha was appointed as a Director was appointed as a Director on 08 Jun 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
Progress on Abbott Pharma Limited was registered on 24 Apr 2008 with Roc Delhi & aged 17 years 8 months as per MCA records. was documented.
The CIN of Abbott Pharma Limited is U24232DL2008PLC177143.
Abbott Pharma Limited is headquartered at 303, Plot No. 2, 3Rd Floor, Vardhman Avon Shopping Plaza, Block-C, Saraswati Vihar, Delhi, Delhi, 110034.
Abbott Pharma Limited was incorporated on 24 April 2008.
The current directors of Abbott Pharma Limited are
The primary industry of Abbott Pharma Limited is Hospital And Medical Care.
Abbott Pharma Limited is unlisted.
The authorized capital of Abbott Pharma Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Abbott Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX